Jpmorgan Chase & CO Nex Immune, Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.61 - $4.68 $411,079 - $1.19 Million	-255,329 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$1.79 - $4.65 $16,405 - $42,617	-9,165 Reduced 3.47%	255,329 $1.08 Million
Q4 2021 Feb 10, 2022	SELL	$4.11 - $15.13 $15,515 - $57,115	-3,775 Reduced 1.41%	264,494 $1.22 Million
Q3 2021 Nov 12, 2021	BUY	$10.32 - $16.9 $2.77 Million - $4.53 Million	268,269 New	268,269 $4.06 Million

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $2.42M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.